New Drug Achieves Pancreatic Cancer Tumor Remission And Prevents Recurrence, Study Suggests

Pancreatic cancer remains one of the deadliest cancers, but researchers may have found a combination therapy to reduce cancer stem cells and stop pancreatic cancer growth. Treatment with gemcitabine and tigatuzumab resulted in the reduction of pancreatic cancer stem cells, caused tumor remission, and significantly increased time-to-tumor progression in 50 percent of treated cases from a median of 54 days to 103 days.

Read the whole article on Science Daily

More from Science Daily